134 related articles for article (PubMed ID: 30663551)
1. Concentration-dependent enrichment of resistant Enterococcus faecium exposed to linezolid in an in vitro dynamic model.
Alieva KN; Golikova MV; Portnoy YA; Dovzhenko SA; Kobrin MB; Zinner SH; Firsov AA
J Chemother; 2018; 30(6-8):364-370. PubMed ID: 30663551
[TBL] [Abstract][Full Text] [Related]
2. Time inside the mutant selection window as a predictor of staphylococcal resistance to linezolid.
Alieva KN; Strukova EN; Golikova MV; Portnoy YA; Zinner SH; Firsov AA
J Antibiot (Tokyo); 2018 May; 71(5):514-521. PubMed ID: 29348530
[TBL] [Abstract][Full Text] [Related]
3. Selection of linezolid-resistant Enterococcus faecium in an in vitro dynamic model: protective effect of doxycycline.
Zinner SH; Gilbert D; Lubenko IY; Greer K; Firsov AA
J Antimicrob Chemother; 2008 Mar; 61(3):629-35. PubMed ID: 18245198
[TBL] [Abstract][Full Text] [Related]
4. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model.
Firsov AA; Alieva KN; Strukova EN; Golikova MV; Portnoy YA; Dovzhenko SA; Kobrin MB; Romanov AV; Edelstein MV; Zinner SH
J Antimicrob Chemother; 2017 Nov; 72(11):3100-3107. PubMed ID: 28981793
[TBL] [Abstract][Full Text] [Related]
5. In vitro analysis of resistance selection by linezolid in vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium.
Allen GP; Bierman BC
Int J Antimicrob Agents; 2009 Jul; 34(1):21-4. PubMed ID: 19243921
[TBL] [Abstract][Full Text] [Related]
6. Predictors of bacterial resistance using in vitro dynamic models: area under the concentration-time curve related to either the minimum inhibitory or mutant prevention antibiotic concentration.
Strukova EN; Portnoy YA; Zinner SH; Firsov AA
J Antimicrob Chemother; 2016 Mar; 71(3):678-84. PubMed ID: 26626718
[TBL] [Abstract][Full Text] [Related]
7. In vitro resistance studies with bacteria that exhibit low mutation frequencies: prediction of "antimutant" linezolid concentrations using a mixed inoculum containing both susceptible and resistant Staphylococcus aureus.
Firsov AA; Golikova MV; Strukova EN; Portnoy YA; Romanov AV; Edelstein MV; Zinner SH
Antimicrob Agents Chemother; 2015 Feb; 59(2):1014-9. PubMed ID: 25451050
[TBL] [Abstract][Full Text] [Related]
8. Predicting antibiotic combination effects on the selection of resistant Staphylococcus aureus: In vitro model studies with linezolid and gentamicin.
Zinner SH; Golikova MV; Strukova EN; Portnoy YA; Firsov AA
Int J Antimicrob Agents; 2018 Dec; 52(6):854-860. PubMed ID: 30236953
[TBL] [Abstract][Full Text] [Related]
9. Detection of a cfr(B) Variant in German Enterococcus faecium Clinical Isolates and the Impact on Linezolid Resistance in Enterococcus spp.
Bender JK; Fleige C; Klare I; Fiedler S; Mischnik A; Mutters NT; Dingle KE; Werner G
PLoS One; 2016; 11(11):e0167042. PubMed ID: 27893790
[TBL] [Abstract][Full Text] [Related]
10. Searching for the Optimal Predictor of Ciprofloxacin Resistance in Klebsiella pneumoniae by Using In Vitro Dynamic Models.
Strukova EN; Portnoy YA; Romanov AV; Edelstein MV; Zinner SH; Firsov AA
Antimicrob Agents Chemother; 2015 Dec; 60(3):1208-15. PubMed ID: 26643328
[TBL] [Abstract][Full Text] [Related]
11. Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report.
Swoboda S; Fritz S; Martignoni ME; Feldhues RA; Hoppe-Tichy T; Buchler MW; Geiss HK
J Antimicrob Chemother; 2005 Oct; 56(4):787-9. PubMed ID: 16143710
[TBL] [Abstract][Full Text] [Related]
12. Enrichment of resistant Staphylococcus aureus at ciprofloxacin concentrations simulated within the mutant selection window: bolus versus continuous infusion.
Firsov AA; Smirnova MV; Strukova EN; Vostrov SN; Portnoy YA; Zinner SH
Int J Antimicrob Agents; 2008 Dec; 32(6):488-93. PubMed ID: 18790614
[TBL] [Abstract][Full Text] [Related]
13. Emergence of linezolid-resistance in vancomycin-resistant Enterococcus faecium ST117 associated with increased linezolid-consumption.
Olearo F; Both A; Belmar Campos C; Hilgarth H; Klupp EM; Hansen JL; Maurer FP; Christner M; Aepfelbacher M; Rohde H
Int J Med Microbiol; 2021 Feb; 311(2):151477. PubMed ID: 33524636
[TBL] [Abstract][Full Text] [Related]
14. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
[TBL] [Abstract][Full Text] [Related]
15. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
16. Bacterial resistance studies using in vitro dynamic models: the predictive power of the mutant prevention and minimum inhibitory antibiotic concentrations.
Firsov AA; Strukova EN; Shlykova DS; Portnoy YA; Kozyreva VK; Edelstein MV; Dovzhenko SA; Kobrin MB; Zinner SH
Antimicrob Agents Chemother; 2013 Oct; 57(10):4956-62. PubMed ID: 23896481
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
Barber KE; Smith JR; Raut A; Rybak MJ
J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
[TBL] [Abstract][Full Text] [Related]
18. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
Sandoe JA; Wysome J; West AP; Heritage J; Wilcox MH
J Antimicrob Chemother; 2006 Apr; 57(4):767-70. PubMed ID: 16464896
[TBL] [Abstract][Full Text] [Related]
19. Tedizolid susceptibility in linezolid- and vancomycin-resistant Enterococcus faecium isolates.
Klupp EM; Both A; Belmar Campos C; Büttner H; König C; Christopeit M; Christner M; Aepfelbacher M; Rohde H
Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1957-1961. PubMed ID: 27525679
[TBL] [Abstract][Full Text] [Related]
20. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
Seedat J; Zick G; Klare I; Konstabel C; Weiler N; Sahly H
Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
